Research facility · founded 2003
Institute for Research in Immunology and Cancer
Montreal, Canada · iric.ca/en
- Citations, last 5 years
- 4 976
- Works, last 5 years
- 581
- h-index
- 255
- Scientists listed
- 126
- Grants since 2016
- 33
Grants received
2024–2027 · fellowship · CIHR Fellowship
HOPE-IOID : Regulation et modulation a differents niveaux du systeme opioide par le nouveau piegeur de peptides opioides ACKR3
Yann Chappe · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2024–2029 · research · Project Grant
Deciphering Mitotic Functions of Phosphoprotein Phosphatases in Drosophila
Vincent Archambault · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2024–2029 · research · Project Grant
Role and therapeutic potential of the atypical MAP kinase ERK3 in basal-like breast cancer progression
Sylvain Meloche · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2024–2025 · research · Project Grant - Priority Announcement: Breast Cancer Research
Role and therapeutic potential of the atypical MAP kinase ERK3 in basal-like breast cancer progression
Sylvain Meloche · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2023–2028 · research · Project Grant
Regulation of RAS driven cellular proliferation by SHOC2 and the MRAS GTPase
Matthew Smith · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2023–2028 · research · Project Grant
Molecular mechanisms and structural determinants of pharmacological chaperone action; therapeutic potential for the treatment of early onset severe obesity
Michel Bouvier · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2023–2028 · research · Project Grant
Regulation of collective cell migration by the kinase Misshapen
Gregory Emery · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2023–2028 · research · Project Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
Trang Hoang · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2022–2027 · research · Project Grant
Regulation of cytokinesis by the novel and conserved flavin-dependent monooxygenase enzymes OSGN-1/OSGIN
Jean-Claude Labbe · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2022–2027 · research · Project Grant
Mechanisms and consequences of spatially controlled G protein-coupled receptor signaling
Michel Bouvier · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2022–2027 · research · Project Grant
Development and preclinical validation of first-in-class dual inhibitors of the atypical MAP kinases ERK3 and ERK4
Sylvain Meloche · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2022–2023 · research · Project Grant - Priority Announcement: Breast Cancer Research
Development and preclinical validation of first-in-class dual inhibitors of the atypical MAP kinases ERK3 and ERK4
Sylvain Meloche · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2021–2026 · research · Project Grant
Understanding Nuclear Envelope Reformation after Mitosis using Drosophila
Vincent Archambault · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2021–2026 · research · Project Grant
Investigation into RAS GTPase control of cell adhesion and proliferation through alternative downstream effectors
Matthew Smith · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2021–2026 · research · Project Grant
Intercellular force transmission and coordination during the migration of squamous carcinoma cells.
Gregory Emery · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2019–2022 · fellowship · CIHR Fellowship
Innovative characterization of structural variants and differential splicing from RNA-sequencing data of 452 primary human AML specimens.
Jean-Francois Spinella · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2019–2020 · fellowship · Travel Awards - Institute Community Support
Analyse epigenomique integrative pour identifier les biomarqueurs potentiels de la leucemie aigue causee par la fusion MLL-AF9
Thomas Milan · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2019–2022 · research · Team Grant: Network of European Funding for Neuroscience Research (NEURON)
A novel paradigm for effective and safer treatment of schizophrenia: biased (ant)agonists with a characterized polypharmacological profile
Michel Bouvier · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2018–2025 · research · Foundation Grant
RAS-MAPK signal transduction in normal and cancer cells
Marc Therrien · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2018–2019 · fellowship · Travel Awards - Institute Community Support
Chemogenomic approach unveils the increased susceptibility of RUNX1-mutated AML to Glucocorticoids
Laura Simon · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2018–2019 · fellowship · Travel Awards - Institute Community Support
Decoding the impact of critically short telomeres on murine embryonic stem cell transcriptional signatures and cell fate commitment
Tsz Wai Chu · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2018 · research · Operating Grants
Rôle de signalisation de la MAP kinase ERK3 dans les cellules initiatrices de tumeurs et dans l'évolution du cancer du sein
Sylvain Meloche · Institute for Research in Immunology and Cancer · funded by Cancer Research Society
2017–2022 · research · Project Grant
Mechanisms Coordinating Polo Kinase Activity and Localization in Cell Division
Vincent Archambault · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2017–2022 · research · Project Grant
A functional surfaceome map of human hematopoietic stem and progenitor cells
Philippe Roux · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2017–2022 · research · Project Grant
Role and therapeutic potential of ERK3/ERK4 MAP kinases in acute kidney injury
Sylvain Meloche · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2017–2018 · research · Project Grant
Intra and intermolecular interactions regulating RAF family members
Marc Therrien · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2017–2022 · research · Project Grant
In vivo regulation of stem cell division and self-renewal
Jean-Claude Labbe · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2017–2018 · research · Project Grant
Control of hematopoietic cell fate by LMO2
Trang Hoang · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2017–2018 · fellowship · Travel Awards - Institute Community Support
Exploring the effect of ATP hydrolysis on condensin ability to compact chromosomes
Roger Palou Marin · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2016–2018 · fellowship · CIHR Fellowship
Assessing the therapeutic potential of E4F1, a new protein of the DNA damage response, in cancer treatment.
Celine Moison · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2016–2021 · research · Project Grant
Characterization of the Cdc37/Hsp90 complex as a regulator of the Notch ligands
Gregory Emery · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2016–2021 · research · Project Grant
Regulation of cell communication during collective cell migration
Gregory Emery · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
2015–2022 · research · Foundation Grant
Chemical and Genetic Interrogation of Human HSC Self-Renewal: Towards Optimal Cord Blood Grafts
Guy Sauvageau · Institute for Research in Immunology and Cancer · funded by Canadian Institutes of Health Research
